Cansino Biologics, Inc. Class ASSE: 688185

Announcement on Voluntary Disclosure of Official Inclusion of the Adsorbed Acellular Pertussis (5-Component), Diphtheria and Tetanus Combined Vaccine (for People Aged 6 and Above) into the Priority Review List

· Issued by Cansino Biologics, Inc. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Official Inclusion of the Adsorbed Acellular Pertussis (5-Component), Diphtheria and Tetanus Combined Vaccine (for People Aged 6 and Above) into the Priority Review List

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis